Latest news with #DhirajSingh
Mint
15 hours ago
- Health
- Mint
Weight loss drug Wegovy launched in India. How different is it from Lilly's Mounjaro? Check cost, other details
Wegovy in India: Adding to other weight loss drugs available in India such as Eli Lilly's Mounjaro, Danish pharma giant Novo Nordisk launched another option Wegovy as a once-a-week injection. Novo Nordisk said that Wegovy is prescribed to help manage weight and lower the risk of serious heart-related events in adults who have existing cardiovascular disease and are either overweight or obese. The launch of Wegovy comes months after Eli Lilly launched its weight loss drug 'Mounjaro' in India in March this year. Injection pens for the weight-loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in Mumbai, India, on Tuesday, June 24, 2025. Novo Nordisk said it will sell its blockbuster weight-loss treatment Wegovy in India starting at $50 a week, tailoring the price to match the pocket of consumers in a nation with the world�s third-largest obese population. Photographer: Dhiraj Singh/Bloomberg Wegovy, which is a prescription medicine, will be available across India to the medical fraternity by June end, mentions a report by Fortune India. It will be sold as an injectable. As per the company, Wegovy's price will range around ₹ 17,345 to rs 26,050, depending on the dose. The weight loss drug will be offered as a once-weekly injection through an easy-to-use pen device, available in dose strengths of : 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, a maintenance dose of 2.4 mg The Wegovy drug targets key areas of the brain that control appetite and food intake, helping to reduce hunger, increase feelings of fullness, and curb food cravings—leading to weight loss over time. The drug also enhances insulin sensitivity and offers benefits in lowering the risk of cardiometabolic events and related health issues, said Novo Nordisk. Wegovy is approved for weight loss, but only if you are above a certain weight. Ozempic (also semaglutide) is used more for diabetes management. Drug name Founded by Availability Primary Use Active Ingredient Wegovy Novo Nordisk Available in India Indicated for weight loss and reducing cardiovascular events Semaglutide Ozempic Novo Nordisk Not officially launched in India Approved for type 2 diabetes; also lowers cardiovascular risk Semaglutide Mounjaro Eli Lilly Available in India Approved for type 2 diabetes; widely used for weight loss Terzepatide Responding to a query about potential of Wegovy and sales expectations from it, Novo Nordisk India Managing Director Vikrant Shrotriya said: "We are not chasing any number in India. What we are chasing is how to really create awareness among patients, healthcare professionals, and also work and collaborate with them in terms of bringing access to the product much faster."
Time of India
23-04-2025
- Entertainment
- Time of India
Bagging deemed university status, FTII to now award degrees
Pune: Students graduating from the Film and Television Institute of India (FTII) will now receive degree certificates from 'FTII University', after the Union education ministry granted the institute deemed university status on April 22. FTII director Dhiraj Singh told TOI that the awarding of degrees and opportunity for research are immediate benefits. "This development also paves the way for better innovation and integration with academics," said Singh, adding, "The university status allows the institute to implement provisions of the New Education Policy (NEP), providing a lot of flexibility and scope for expansion." Alongside FTII, the Satyajit Ray Film and Television Institute (SRFTI) in Kolkata has also been granted university status. Both institutes will now participate in the National Institutional Ranking Framework (NIRF) and integrate with the Academic Bank of Credits (ABC). The education ministry, in its announcement regarding the grant of university status to FTII, said the status was granted under section 3 of the UGC Act, 1956. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Sutton: Born Between 1940-1975 You May Be Eligible For This Life Cover Reassured Get Quote Undo "Both institutes will launch doctoral, research, and innovative academic programmes and will adhere to UGC norms and NEP 2020 guidelines," said the statement. The new status empowers both institutes to award degrees rather than just diplomas and also offer doctoral programmes. Singh further said, "Deemed to be university status is a major milestone in the glorious journey of FTII. This recognition under the distinct category allows FTII to retain its unique identity while embracing the benefits of being a world-class university." FTII was set up by Govt of India in 1960, in the premises of the erstwhile Prabhat Studios in Pune. Formerly known as the 'Film Institute of India', in 1971 its name was changed to became known as the 'Film and Television Institute of India'. It soon started in-service training programmes for Doordarshan, India's public broadcaster. The television training wing, earlier functioning in New Delhi, shifted to Pune in 1974. Thereafter, the institute became fully aided by the Union ministry of information and broadcasting. In 2017, the Association of Indian Universities (AIU) granted equivalence to six PG diploma programmes of the institute with a master's degree. Meanwhile, SRFTI in Kolkata, named after legendary auteur Satyajit Ray, was the second national centre of cinema education established in 1995 by GOI as an autonomous academic institution under the I&B ministry.
